Fig. 1From: A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocolDevelopment of a Multimodal Artificial Intelligence Tool in Prostate CancerBack to article page
